Literature DB >> 15956757

Coevolution of the relaxin-like peptides and their receptors.

Tracey N Wilkinson1, Terence P Speed, Geoffrey W Tregear, Ross A D Bathgate.   

Abstract

Currently, four relaxin peptide family receptors are known: LGR7 is the relaxin receptor, although it also interacts specifically with relaxin-3; LGR8 is the insulin-like factor 3 (INSL3) receptor; and GPCR135 or the somatostatin- and angiotensin-like peptide receptor (SALPR) and GPCR142 are both specific relaxin-3 receptors. Because these receptors coevolved together with their relaxin ligands, phylogenetic analysis of these sequences can provide insight into peptide-receptor interactions and even predict interacting partners for INSL4, INSL5, and INSL6, the receptors for which are unknown.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956757     DOI: 10.1196/annals.1282.080

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.

Authors:  Martina Kocan; Sheng Yu Ang; Roger J Summers
Journal:  Neurochem Res       Date:  2015-08-21       Impact factor: 3.996

Review 2.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

3.  Origin of INSL3-mediated testicular descent in therian mammals.

Authors:  Jae-Il Park; Jenia Semyonov; Chia Lin Chang; Wei Yi; Wesley Warren; Sheau Yu Teddy Hsu
Journal:  Genome Res       Date:  2008-05-07       Impact factor: 9.043

Review 4.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 5.  Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.

Authors:  Sherie Ma; Craig M Smith; Anna Blasiak; Andrew L Gundlach
Journal:  Br J Pharmacol       Date:  2016-12-04       Impact factor: 8.739

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants.

Authors:  David Speck; Gunnar Kleinau; Mark Meininghaus; Antje Erbe; Alexandra Einfeldt; Michal Szczepek; Patrick Scheerer; Vera Pütter
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

8.  Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3.

Authors:  Ross A D Bathgate; Maria H Y Oh; W J Jason Ling; Quentin Kaas; M Akhter Hossain; Paul R Gooley; K Johan Rosengren
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-22       Impact factor: 5.555

9.  Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules.

Authors:  Shoni Bruell; Roy C K Kong; Emma J Petrie; Brad Hoare; John D Wade; Daniel J Scott; Paul R Gooley; Ross A D Bathgate
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-11       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.